Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 1/2010

01-05-2010 | Poster presentation

Genetic analysis of lobular carcinoma in situ and associated invasive lobular cancer

Authors: LR Yates, A Jones, H Patel, A Mackay, C Gillett, S Pinder, I Tomlinson, R Roylance, EJ Sawyer

Published in: Breast Cancer Research | Special Issue 1/2010

Login to get access

Excerpt

This is a pilot study to assess the feasibility of performing SNP-loss of heterozygosity (LOH) on micro-dissected formalin-fixed paraffin-embedded (FFPE) lobular carcinoma in situ (LCIS) tissue and to examine the genetic relationship between LCIS and associated invasive lobular carcinomas (ILC). …
Metadata
Title
Genetic analysis of lobular carcinoma in situ and associated invasive lobular cancer
Authors
LR Yates
A Jones
H Patel
A Mackay
C Gillett
S Pinder
I Tomlinson
R Roylance
EJ Sawyer
Publication date
01-05-2010
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 1/2010
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr2502

Other articles of this Special Issue 1/2010

Breast Cancer Research 1/2010 Go to the issue

Poster presentation

Identification of proteins and signalling pathways involved in neoadjuvant chemotherapy responsiveness of breast tumours using proteomics

Poster presentation

A novel tumour-based test to identify breast cancer due to BRCA1 and BRCA2 mutations

Poster presentation

Insulin-like growth factor binding protein-2 alters the sensitivity of breast cancer cells to chemotherapy

Poster presentation

Targeting DNA replication before it starts: Cdc7 as a therapeutic target in p53 mutant Her2 and triple negative breast cancer

Poster presentation

Modelling breast cancer in a three-dimensional heterotypic culture system

Poster presentation

Intensity and features of acute postoperative pain after mastectomy and breast-conserving surgery
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits